Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials
Authors:
- Clémence BretonCBClémence Breton
- Thomas AparicioTAThomas Aparicio
- Karine Le MalicotKMKarine Le Malicot
- Michel DucreuxMDMichel Ducreux
- Thierry LecomteTLThierry Lecomte
- Jean-Baptiste BachetJBJean-Baptiste Bachet
- Julien TaiebJTJulien Taieb
- Jean-Louis LegouxJLJean-Louis Legoux
- Aimery De GramontAGAimery De Gramont
- Jaafar BennounaJBJaafar Bennouna
- Olivier BouchéOBOlivier Bouché
- Olayide BoussariOBOlayide Boussari
- 1 August 2021
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 153, 40-50
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- Servier
This publication has 16 references indexed in Scilit:
- High-Dose FOLFIRI plus Bevacizumab in the Treatment of Metastatic Colorectal Cancer Patients with Two Different UGT1A1 Genotypes: FFCD 0504 StudyMolecular Cancer Therapeutics, 2015
- Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)Annals of Oncology, 2015
- Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly PatientsJournal of Clinical Oncology, 2013
- Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trialThe Lancet Oncology, 2011
- Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR StudyThe Oncologist, 2011
- Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2009
- Randomised Trial Comparing Three Different Schedules of Infusional 5FU and Raltitrexed Alone as First-Line Therapy in Metastatic Colorectal CancerOncology, 2006
- Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2004
- Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patientsAnnals of Oncology, 2002
- Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.Journal of Clinical Oncology, 1997